Anthropic is pushing Claude into healthcare, but the real battle isn't clinical success; it’s controlling the future of proprietary medical data.
The push for safer inhalation devices in drug policy hides a darker truth about social management, analyzed here.
We're obsessed with 'small wins' science, but the real cost is lost ambition. Unpacking the dopamine trap.
DXC Technology solidifies its SAP position, but the real story behind this RISE with SAP validation hints at deeper industry consolidation.
The promised 'four paths forward for US scientists' are a smokescreen. The real crisis in **US science funding** is deeper, driven by political capture.
Fujitsu's blockchain experiment in green steel is a PR move masking the real cost of industrial decarbonization. Is this tracking tech or just greenwashing?
The battle against malicious AI-generated sexualised images is being lost in plain sight. Technology's proposed fixes are theater.
The claim that organic chemistry degrades without intelligent direction is shaking evolutionary biology. Is this the end of pure chance in abiogenesis?
The sudden exit of Hennepin Healthcare's interim leader signals deeper turmoil. We dissect the power struggle behind this crucial Minneapolis health system.
Global powers are desperately trying to update the NPT, but emerging technologies like AI and quantum computing are rendering old nuclear frameworks useless.
The new GRPM exhibit champions 'Backyard Adventures,' but it masks a deeper crisis in **science education** and **STEM engagement**.
New data reveals most US adults carry risk factors for a fatal syndrome. This isn't just about lifestyle; it’s about systemic failure in preventive health.